7 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Fixed Dose Combination drugs for Secondary Cardiovascular Prevention (FOCUS)
Date du début: 1 juil. 2010, Date de fin: 30 juin 2014,
Cardiovascular diseases (CVD) are the leading cause of death worldwide, and their incidence is increasing sharply in developing countries. Two insufficiently addressed factors contribute to increased morbidity and mortality, threatening the effectiveness of any health system: poor patient adherence to treatment, and limited access to medication in resource-poor countries and regions. To address th ...
Voir le projet
9
Participants partenaires
TERMINÉ
European coordination action on human biomonitoring (COPHES)
Date du début: 1 déc. 2009, Date de fin: 30 nov. 2012,
This proposal has been elaborated by a consortium of 35 partners coming from 27 European countries and including scientists, government institutions and authorities, NGOs and industry. The main goal is to develop a coherent approach to HBM in Europe as requested by ACTION 3 of the EU Environment and Health Action Plan through coordination of ongoing and planned HBM activities. The project will exp ...
Voir le projet
40
Participants partenaires
TERMINÉ
"PRe-clinicAl studies of a PSA-based human vaccine candidate targeting visceral, cutaneOus and mucocutaneous Leishmaniasis and Development of the associated procedures for further clinical trials" (RAPSODI)
Date du début: 1 janv. 2009, Date de fin: 30 juin 2012,
"The global aim of RAPSODI is : · to develop a human vaccine candidate against most or all Leishmania species that cause the most severe leishmaniasis in the world. An unique vaccinal solution will thus be provided to protect against the various clinical phenotypes (namely visceral, cutaneous and mucocutaneaous leishmaniasis, VL, CL and ML respectively). · to establish all the associated procedure ...
Voir le projet
9
Participants partenaires
TERMINÉ
Improving science advice for health in Europe, EuSANH (EuSANH-ISA)
Date du début: 1 févr. 2009, Date de fin: 31 janv. 2012,
The general objective of this project is to improve the quality, effectiveness and efficiency of science advice for health across Europe. Science advice is any recommendation for policy action based on scientific knowledge, considering also expert judgment, ethical and societal values, and experience from relevant stakeholders. Many EU Member States have national science advisory bodies. However, ...
Voir le projet
6
Participants partenaires
TERMINÉ
Developing and validating disease management evaluation methods for European health care systems (DISMEVAL)
Date du début: 1 janv. 2009, Date de fin: 31 déc. 2011,
Chronic health conditions that impose a heavy burden on society and account for a large share of health care costs. Better prevention and management could potentially decrease costs and improve quality of care and health outcomes. An important means of accomplishing these goals is through the use of disease management (DM) interventions that educate patients about prevention and health management ...
Voir le projet
10
Participants partenaires
TERMINÉ
Nurse Forecasting: Human Resources Planning in Nursing (RN4CAST)
Date du début: 1 janv. 2009, Date de fin: 31 déc. 2011,
"Current human resources planning models in nursing are unreliable and ineffective as they consider volumes, but ignore effects on quality in patient care. The project RN4CAST aims innovative forecasting methods by addressing not only volumes, but quality of nursing staff as well as quality of patient care. RN4CAST is a consortium of 15 partners that will quantify in 11 European countries-Belgium, ...
Voir le projet
15
Participants partenaires
TERMINÉ
EUROpean network of trans-national collaborative RTD in the field of NANOMEDicine (EuroNanoMed)
Date du début: 1 janv. 2009, Date de fin: 31 déc. 2011,
Nanomedicine is an emerging field with a large potential for developing public welfare and economic growth. Critical issues for bringing up this potential in Europe concern especially the maturity of the economic players and their capability to move effectively innovation from knowledge to industrial technology and to clinical and public health applications. Industrial players need therefore to co ...
Voir le projet